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Abstract: Pediatric aggression is common in human societies, mainly presenting as impulsive 
aggression or predatory aggression. Numerous psychiatric disorders can contain aggression as 
a symptom, leading to difficulties in diagnosis and treatment. This review focuses on the bio-
logical systems that affect pediatric aggression. We review the hypothalamic–pituitary–adrenal 
(HPA) axis, the hypothalamic–pituitary–gonadal (HPG) axis, and the mechanisms by which 
these axes influence the body and mind of aggressive children and adolescents. Although this 
review focuses on the HPA and HPG axes, it is important to note that other biological systems 
have relationships with these two axes. Based on the results of the studies reviewed, elevated 
cortisol concentrations were associated with impulsive aggression, whereas, low levels of cortisol 
were associated with callous-unemotional traits similar to predatory aggression. Higher levels 
of dehydroepiandrosterone were correlated with higher levels of aggression as were higher 
levels of testosterone. However, there have been discrepancies in the results between various 
studies, indicating the need for more research on hormonal levels and pediatric aggression. In 
the future, hormonal levels may be useful in determining what treatments will work best for 
certain pediatric patients.
Keywords: youth, cortisol, adrenocorticotropin-releasing hormone, corticotropin-releasing 
hormone, HPA axis, HPG axis
Introduction
Though difficult to define, aggression is ubiquitous in human societies and transcends 
age, race, and societal milieu. In children, differentiating between pathologic aggressive 
behavior and developmentally-bound aggression can be difficult. To this end, many 
children may exhibit aggression in the context of tantrums or angry outbursts. There 
may be problems in differentiating between this developmentally-bound aggression 
of a child and pathological pediatric aggression.1 Pathologic pediatric aggression may 
be more severe than developmentally-bound aggression, in terms of incidence, length, 
and amount of aggression.1
In the pediatric population, pathologic aggression can be physical or verbal and 
may be directed towards self or others. Physical aggression can be further character-
ized as impulsive, reactive, predatory, or premeditated. Impulsive aggression usually 
occurs in response to a stimulus, whereas predatory aggression is usually planned in 
advance of the act.2 Thus, pediatric aggression is a nonspecific symptom that tran-
scends a number of psychiatric disorders. The diagnostic complexity of child and 
adolescent aggression further relates to the fact that multiple illnesses may involve 
aggression. Aggressive behaviors may be seen in attention-deficit or hyperactivity Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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disorder (ADHD), posttraumatic stress   disorder (PTSD), 
and oppositional defiant disorder.3 It can be challenging to 
determine the primary psychiatric diagnosis and what kind of 
predominant aggressive pattern (impulsive or premeditated) 
exists. This dilemma may complicate the treatment of the two 
different types of aggression as they may be approached in 
different ways.4
Treatment of pediatric aggression is often complicated by 
difficulties related to diagnostic issues, multiple medications 
used by clinicians, and the variety of psychological and envi-
ronmental factors, which may directly affect the expression 
of aggression in youth. Psychopharmacologic treatment may 
require a long period, empiric trials of multiple medications 
until desired effects are attained. Thus, the main causes of the 
aggression need to be targeted and treated for the aggression 
to abate.5 A myriad of medications can be used to treat pedi-
atric aggression, including antipsychotics, antidepressants, 
antiadrenergics, and mood stabilizers. Moreover, a number of 
nonpsychopharmacologic interventions, including different 
psychotherapies, are available for the treatment of pediatric 
aggression associated with a number of mental illnesses.
Aggressive behavior in children can result from a variety 
of experiences. Accumulating evidence from both clinical 
studies and investigations conducted in lower animals sug-
gests that early life stress is a significant risk factor for the 
development of pathologic aggression.6–10 Early life stress can 
take many forms including early social deprivation or expo-
sure to trauma, abuse, or neglect.6 Many studies have found 
functional and structural differences in the brains of those 
exposed to maltreatment.11 Biological factors of   pediatric 
aggression can be related to neuroendocrine abnormalities, 
genetics, and substance abuse.12 Moreover, deficits in social 
skills have also been linked to pediatric aggression.13 Children 
who are not able to adjust to a social environment may act 
out in an aggressive manner.
Although it is evident that pediatric aggression has many 
causes and contributing factors, a number of   biological 
findings have been associated with pediatric aggression 
and will be reviewed in the context of selected aspects of 
  neuroendocrine function and dysfunction.
Neurochemical systems  
and pediatric aggression
A constellation of neurochemical systems have been impli-
cated in the physiology of aggression. Although herein we 
will focus primarily on the hypothalamic–pituitary–adrenal 
(HPA) axis, this system has a number of intimate relationships 
with other neuroendocrine systems, which are important for 
  clinicians and neurobiologists to consider. In this review, 
the central monoaminergic systems (eg,   norepinephrine and 
dopamine) and the serotonin system will be briefly reviewed 
with regard to their relationships with both aggression 
and the HPA axis.
The dopaminergic system consists of cell bodies that 
are primarily localized in the ventral tegmental area of the 
midbrain and the nucleus accumbens. These nuclei give rise 
to a number of tracts that project throughout various brain 
regions, which functionally subserve emotional regulation, 
motor command, cognitive processing, and neuroendo-
crine control. With regard to the issue of neuroendocrine 
control, the anterior pituitary, which ultimately modulates 
the release of the end products of the major hormones (the 
focus of this review), is coated with dopamine receptors 
highlighting the influence of the dopamine system on the 
HPA and hypothalamic–pituitary–gonadal (HPG) axes. In 
fact, the relationship between central nervous system dop-
amine release and elaborates of the HPA axis is complicated 
and likely reflects bidirectional influences and common 
stimuli. For example, both preclinical and clinical studies 
document cortisol-induced increases in central dopaminer-
gic activity.14 With specific regard to impulsive aggression, 
a study of adults, which assessed cerebral blood flow using 
single   photon emission computed tomography, suggests that 
regional blood flow may be increased in the nucleus accum-
bens, which itself directs important fibers to limbic regions;15 
however, it remains unknown whether individuals without 
PTSD but with impulsive aggression would have similar 
increases in this region. Interestingly, from a neurochemical 
standpoint, cerebrospinal fluid sampling studies in adults 
have consistently linked high levels of the major dopamine 
metabolite, homovanillic acid, a finding consistent with 
high dopamine turnover, with higher levels of aggression 
in violent forensic samples.16 Moreover, the same has been 
observed in men convicted of murder.17 Similarly, levels of 
this compound are also abnormal in youth with aggression 
and comorbid ADHD.18 Indirect clinical evidence for the role 
of dopamine in the involvement of aggression includes the 
observation that patients, both youth and adults, who ingest 
cocaine (which increases postsynaptic effects of dopamine) 
become aggressive.19 In addition, drugs that block central 
dopamine receptors (eg, first and second generation antip-
sychotics) often have antiaggressive effects.
The catecholamine norepinephrine plays a critical role as 
one of the principal mediators of the mammalian response to 
stress. Thus, it is not surprising that it plays a central role in the 
modulation of aggression in both humans and lower   animals. Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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Central norepinephrine production occurs in the locus coer-
uleus, whose cell bodies project to a   constellation of struc-
tures that are altered or implicated in the   pathophysiology 
of   aggression, including the prefrontal cortex, amygdala, 
  hippocampus, hypothalamus, periaqueductal gray matter and, 
the thalamus.20 As with the dopaminergic system, the rela-
tionship between norepinephrine and other systems, which 
have been linked to aggression, is complicated. For example, 
administration of β-receptor agonists increases secretion of 
adrenocorticotropin-releasing hormone (ACTH), and in many 
conditions, the concentrations of cortisol and norepinephrine 
covary with one another. With regard to studies of aggres-
sion and its relationship with the concentrations of plasma 
norepinephrine, concentrations of this catecholamine have 
been found to be higher in healthy subjects with high–normal 
aggression than in those with   low–normal aggressiveness21; 
however, not all studies of peripheral norepinephrine have 
observed these effects,22 which is likely related to the fact 
that concentrations of peripheral norepinephrine are poorly 
reflective of central norepinephrine concentrations.20,23 
  Further indirect support for the involvement of this system 
in aggression is provided by the clinically used postsynaptic 
β-receptor antagonists and presynaptic α2 receptor agonists 
to attenuate central noradrenergic tone, which are often 
used to decrease aggressive behaviors in youth with certain 
mental illnesses.24
Nearly, a quarter century of accumulating evidence has 
firmly established a link between the serotonergic system 
and the aggression16,18,25 and have been reviewed extensively 
in the literature.26 The serotonin system, whose cell bodies 
reside in the raphe nuclei of the brainstem, projects both 
rostrally and caudally and innervate a diverse group of brain 
regions including diencephalic and cortical structures, many 
of which have also been linked to aggression with functional 
imaging studies of aggressive adults and youth.27–29 Although 
an oversimplified summary neglects many nuances specific to 
individual history, individual attachment, individual psycho-
pathology, etc, the serotonergic system is generally thought 
to be in a state of hypofunction in aggressive individuals. In 
a recent study of violent offenders, low cerebrospinal fluid 
concentrations of the major serotonin metabolite, and marker 
of serotonergic neurotransmission,   5-hydroxyindolacetic 
acid, were found to be high suggesting a link between “the 
outward-directed aggression of psychopathy to serotonergic 
hypofunctioning”.16 Importantly, the serotonergic system 
operates in concert with many of the other systems described 
in this review and elsewhere, which have been implicated or 
could   theoretically be involved in aggression, including the 
  vigilance-promoting and   arousal-regulating peptide orexin,30 
the aggression   modulating steroid hormone testosterone,31 
thyroid function,32 and the covarying monoamine dop-
amine.23 Finally, from a pharmacologic standpoint, the 
distribution of brain 5-HT2a receptors is markedly different 
in adults with histories of impulsive aggression as compared 
with those without, and agents, which act at these receptors 
(eg, second-generation antipsychotics), are often used clini-
cally in treating symptoms of impulsive aggression.33
The HPA axis and pediatric 
aggression
Despite the significance of these monoaminergic systems, the 
HPA axis, which links the central nervous system with the 
peripheral response to stress,34 has been the focus of many 
studies of pediatric aggression because it is one of the main 
regulators of stress in the body.35 The HPA axis instigates a 
cascade effect that eventually results in the production of 
cortisol.35 In times of stress and in certain psychiatric condi-
tions, the hypothalamus releases the peptide hormone called 
corticotrophin-releasing hormone (CRH), which stimulates 
the pituitary to secrete ACTH (Figure 1A). In response to the 
ACTH, the adrenal cortex releases glucocorticoids. Of these 
glucocorticoids, cortisol is perhaps the most studied and has 
intimate relationships with a diverse number of systems, 
inlcuding the immune system and the reproductive system, 
and even effects respiratory and cardiac functions. More-
over, this system is regulated through a series of negative 
feedback loops both at the level of the hypothalamus and 
pituitary wherein cortisol secretion   inhibits release of CRH 
and ACTH, respectively.34
Several studies have examined the function of HPA axis 
and the concentrations of cortisol in pediatric aggression. 
However, the results from the various studies have not 
been consistent. One study found that prepubertal chil-
dren (aged 8–12 years, male and female) with disruptive 
behavior disorders had lower cortisol levels associated with 
a stress-inducing challenge.36 However, this study did not 
characterize the severity of aggression or type. The exact 
mechanisms involved with low levels of HPA axis activity 
are unknown. Therefore, it cannot be said how this would 
affect hormone concentrations in the body. McBurnett 
et al37 examined the relationship between plasma cortisol 
concentrations and aggression in 38 subjects (aged 7–12 
years; male and female) and observed that low cortisol 
levels were associated with patterns of aggression and 
early onset of aggression in male children.37   Interestingly, 
a low variability with low cortisol levels over the long Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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term (collected at the second and fourth year of the study) 
was predictive of severe persistent pediatric aggression.37 
In a subsequent study that focused on pediatric aggres-
sion rather than disruptive behavior disorders diminished 
postchallenge cortisol secretion corresponded to higher 
levels of aggression in 10 to 14-year-old children, but 
only in the presence of low sympathetic nervous system 
activity, as assessed by salivary α-amylase concentrations, 
a surrogate of noradrenergic activity.38 This study provided 
evidence for the need to study more than one system at a 
time since biological systems are connected. Interestingly, 
in a study of males aged 10–12 years, it was noted that 
low cortisol levels correlated with aggressive behavior and 
impulsivity 5 years later (at ages 15–17 years).39 However, 
to our knowledge, the potential predictive value of cortisol 
has not been assessed with regard to subsequent short-term   
aggression.
In an important study of the type of pediatric aggression 
and cortisol levels, Lopez-Duran et al40 evaluated   cortisol 
reactivity in 73 6- to 7-year-old children and noted that 
subjects with patterns of reactive aggression had higher 
cortisol reactivity than the children with no aggression or 
proactive aggression.40 Moreover, in another study, Loney 
et al41 found that low basal cortisol   levels were correlated 
with callous unemotional traits in male adolescents, but a 
similar relationship was not observed in female adolescents.41 
This finding was consistent with their hypothesis that callous 
unemotional traits would be   associated with low resting corti-
sol levels due to the low emotional reactivity. Serum cortisol 
concentrations can be considered biomarkers of “emotional 
reactivity”, and thus, levels of cortisol may potentially help 
to predict the type of aggression and help with diagnosis 
and treatment.41
In contrast to the aforementioned studies, Sondeijker et al 
did not find a relationship between circulating cortisol con-
centrations and aggressive or disruptive behaviors.42 However, 
the children in this study were from the general population, 
instead of high-risk children with more severe behavioral 
problems. Hence, it would be important to carefully consider 
the characteristics of the groups of children to be studied 
when measuring hormonal levels. In future pediatric studies, 
three groups including a low-risk clinical group, a high-risk 
clinical group, and a control nonclinical group would allow 
researchers to determine how cortisol levels differ between 
children with a range of risk for aggression (from none to 
high levels). The level of risk for potential pediatric aggres-
sion and violence in child psychiatry inpatient units could 
be measured using the brief rating of aggression by children 
and adolescents.43 In future neuroendocrine pediatric aggres-
sion studies, it is also important to differentiate between 
patterns of callous unemotional aggression and impulsive 
aggression.
Testosterone
(increased)
Cortisol (increased)
DHEA-S (increased) DHEA-S (increased)
Cortisol (low)
DHEA
ACTH ACTHA CTH
CRH CRH CRH
C. B. A.
Cortisol
Figure 1 A) Neuroendocrine function among healthy children and adolescents; B) Children and adolescents with impulsive aggression; C) Children and adolescents with 
callous, unemotional traits. Solid arrows represent stimulation and dashed lines represent inhibitory pathways.
Abbreviations: CRH, corticotrophin-releasing hormone; ACTH, adrenocorticotropin-releasing hormone; DHeA, dehydroepiandrosterone; DHeA-S, dehydroepiandro-
sterone sulfate.Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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Given the above findings, it is important to consider the 
etiology of the HPA pathology and pediatric aggression. 
In response to certain types of early life stress, the HPA axis 
may become dysregulated. This HPA dysregulation may 
result in a vulnerability for the development of psychopa-
thology and antisocial behavior.44 To this end, structural 
neuroanatomic differences in those exposed to maltreatment 
may be related to increased cortisol concentrations, which 
specifically alter the structure of glucocorticoid sensitive 
areas of the brain.45
The neurobiology of attachment is highly relevant 
for understanding hormones and pediatric aggression. 
Disorganized attachment, in which a child has no abil-
ity to organize a response to elicit care under stress, is a 
risk factor for the development of aggressive behavior in 
school-aged   children.46 Several studies have also shown a 
correlation between cortisol levels and attachment pattern. 
A study investigating prenatal cortisol exposure found 
that increased amniotic fluid levels of cortisol negatively 
impacted infants’ cognitive ability, but this effect only 
persisted if the infant-mother dyad developed an insecure 
attachment.47 Infants whose   mothers had high-quality 
maternal behavior have more normal cortisol recovery 
in response to stress.48 Understanding the neurobiologi-
cal mechanism of attachment-related pathology may help 
design treatments to abate HPA dysregulation. Accord-
ingly, a recent study demonstrated that attachment-based 
psychotherapeutic interventions in children in foster care 
resulted in normalization of cortisol levels in response to 
social stressors.49
The effects of sex hormones  
and their precursors on pediatric 
aggression
Dehydroepiandrosterone (DHEA), a neurosteroid produced 
by the adrenal cortex and the brain,50,51 is a precursor to sex 
hormones, such as testosterone and estrogen. A more stable 
and sulfated form of this compound, dehydroepiandrosterone 
sulfate (DHEA-S), is commonly measured secondary to its 
inherent stability. Circulating DHEA levels increase quickly 
(around 7 years old in females and around 9 years old in 
males) and then decline later in life.51
Not surprisingly, DHEA-S has been studied in child and 
adolescent psychiatry to understand its effect on aggressive 
behavior. In a study of 16 adolescents with conduct disor-
der, the circulating DHEA-S concentrations were measured 
in relation to observed aggression (as measured using the 
Overt Aggression Scales and the Child Behavior   Checklist). 
Higher DHEA-S levels were found in the   adolescents with 
conduct disorder as compared with a healthy group of 
adolescents.51 Another study found that in male children 
(aged 8–12 years) with pathological aggression and conduct 
disorder, the DHEA-S levels were significantly higher than 
control subjects. Using ratings by parents and teachers, this 
study found that the high DHEA-S levels were associated 
with antisocial behaviors and aggression in these school-aged 
children.52 Similar results were found in a   German study 
that compared DHEA-S levels in 28 boys aged 10–18 years 
with conduct disorder and 13 comparison   subjects.53 
The   subjects with conduct disorder had high DHEA-S 
  concentrations as compared with the comparison subjects.
Testosterone, an androgen that circulates throughout 
human blood and readily crosses the blood–brain barrier, is 
present in both males and females but is commonly known 
as the male sex hormone.54 Fluctuations of testosterone 
concentration may be associated with aggression and 
mood changes.55 Scerbo and Kolko56 evaluated salivary 
testosterone and cortisol concentrations in 40 children, 
aged 7–14 years (37 boys and three girls), with aggressive 
behaviors and observed an association between higher 
testosterone   levels and aggressive behaviors. In addition, 
the higher cortisol concentrations were associated with 
internalizing behaviors.56 Similarly, in adolescent males, 
higher testosterone levels were associated with provoked 
verbal and physical aggression, a finding suggesting that 
reactive impulsive aggression is correlated with higher 
testosterone levels.54
Importantly, however, not all studies have observed dif-
ferences in serum testosterone levels between aggressive and 
nonaggressive boys.57 In this study of 4- to 10-year olds, there 
was no evidence to suggest a relationship between testoster-
one levels and aggressive behaviors in prepubertal children. 
To our surprise, the relationship between aggressive behavior 
and testosterone or gonadal function remains to be developed 
and, thus, suggests a more limited potential for testosterone 
as a biomarker for pediatric aggression.
Future directions
The existing data suggest that hormonal levels (eg, in saliva, 
serum, plasma, urine, etc) could be of potential clinical 
utility in that concentrations might assist in clarifying the 
subtype of pediatric aggression, which directly relates to 
subtype-specific psychopharmacologic or psychotherapeutic 
treatments. Thus, given the evidence that certain hormonal 
concentrations are associated with   pediatric   aggression and 
may be specific to the type of pediatric   aggression, it is not Neuropsychiatric Disease and Treatment 2010:6 submit your manuscript | www.dovepress.com
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unreasonable to suppose that salivary hormone assays can 
help in identifying pediatric patients that would respond best 
to certain treatments.
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